Citicoline as Neuroprotector in Preterm

Sherief Abd-Elsalam

Status and phase: Enrolling; Phase 3

Conditions: Pre-Term

Treatments: Drug: Placebo oral tablet; Drug: Citicoline

Study type: Interventional

Funder types: Other

Identifiers

NCT03966170

Citicoline

Details and patient eligibility

About

Citicoline as neuroprotector in preterm

Full description

Efficacy of Citicoline as neuroprotector in preterm; A randomized controlled trial.

Enrollment: 40 estimated patients

Sex: All

Ages: Under 1 month old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Preterm on CPAP or ventilator

Exclusion criteria

• Multiple congenital anomalies

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

40 participants in 2 patient groups, including a placebo group

Citicoline

Experimental group

Description:

Citicoline as neuroprotector

Treatment:

Drug: Citicoline

Placebo drug

Placebo Comparator group

Description:

Placebo

Treatment:

Drug: Placebo oral tablet